Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
An NIH-sponsored study assessed boosters for adults fully vaccinated with any authorized or approved COVID-19 vaccine.
Older and immunocompromised people and those with underlying health conditions could benefit most from additional shots.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.